CONNECTICUT

Now, let’s match you with the right doctor.

Approved or your money back.

Get Approved Today!

incoming call from a female doctor

HOW IT WORKS

A little bit about us.

Leafy DOC is a healthcare technology platform with a team of technology enthusiasts and state-licensed doctors. We believe all people deserve access to medical products if they think it might improve their quality of life. We help by connecting patients and doctors online, to provide evaluations for each individual looking to better their life.

Whether you’re a connoisseur or thinking of becoming a first-time medical patient, our doctors will listen to your needs and give you an honest opinion about whether they think can help.

Connecticut FAqs

  • You must be able to provide proof of your Connecticut residency
  • You are being treated for a debilitating medical condition by a Connecticut-licensed physician or advanced practice registered nurse.

Below are the medical conditions you must have by Illinois law. You must also have medical records from the last year that state you have this condition (a doctor’s note is fine, but real medical records is the best). Again, we will help get this for you.

For Adults, Debilitating Medical Conditions Include:

  • Amyotrophic Lateral Sclerosis (Effective 2016)*
  • Cachexia (Effective 2012)
  • Cancer (Effective 2012)
  • Cerebral Palsy (Effective 2016)
  • Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*
  • Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)*
  • Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)*
  • Crohn’s Disease (Effective 2012)
  • Cystic Fibrosis (Effective 2016)
  • Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012)
  • Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)*
  • Epilepsy (Effective 2012)
  • Glaucoma (Effective 2012)
  • Hydrocephalus with Intractable Headache (Effective 2018)*
  • Interstitial Cystitis (Effective 2019)*
  • Intractable Headache Syndromes (Effective 2018)*
  • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*
  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable
  • MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)*
  • Multiple Sclerosis (Effective 2012)
  • Muscular Dystrophy (Effective 2018)*
  • Neuropathic Facial Pain (Effective 2018)*
  • Osteogenesis Imperfecta (Effective 2018)*
  • Parkinson’s Disease (Effective 2012)
  • Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency
  • Post Herpetic Neuralgia (Effective 2018)*
  • Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)*
  • Post-Traumatic Stress Disorder (Effective 2012)
  • Severe Psoriasis and Psoriatic Arthritis (Effective 2016)*
  • Severe Rheumatoid Arthritis (Effective 2018)*
  • Sickle Cell Disease (Effective 2016)*
  • Spasticity (Effective 2016)
  • Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*
  • Syndrome (Effective 2012)
  • Terminal Illness Requiring End-Of-Life Care (Effective 2016)
  • Tourette Syndrome (Effective 2019)*
  • Ulcerative Colitis (Effective 2016)*
  • Uncontrolled Intractable Seizure Disorder (Effective 2016)
  • Vulvodynia and Vulvar Burning (Effective 2019)*
  • Wasting Syndrome (Effective 2012)

For Patients Under 18, Debilitating Medical Conditions Include:

  • Cerebral Palsy (Effective 2016)
  • Cystic Fibrosis (Effective 2016)
  • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*
  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable
  • Muscular Dystrophy (Effective 2018)*
  • Osteogenesis Imperfecta (Effective 2018)*
  • Severe Epilepsy (Effective 2016)
  • Spasticity (Effective 2016)
  • Terminal Illness Requiring End-Of-Life Care (Effective 2016)
  • Tourette Syndrome for patients who have failed standard medical treatment (Effective 2019)*
  • Uncontrolled Intractable Seizure Disorder (Effective 2016)

Conditions were approved by the Regulation Review Committee via the recommendation of the Board of Physicians and Commissioner of Consumer Protection.

Patients must register with the State of CT for a $100 fee.